Rate Of Return
OPEN Gain Hunter$Mindray(300760.SZ) remains a steady and solid company even within the A-share medical device sector. Although affected by DRP and DRG cost controls, I believe it will eventually weed out companies with relatively poor R&D efficiency. Mindray is still the industry leader.
Long Image
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments